Latest Tissue plasminogen activator Stories
Approximately 14 percent of all strokes occur during sleep, preventing many from getting clot-busting treatment, according to a study.
CENTENNIAL, Colo., May 2, 2011 /PRNewswire/ -- Bailey Carlson, 17, appears to live a typical teenage life. She is focused on school, friends and sleepovers.
Dr. George Rappardâ€™s Site is cleared to begin enrolling patients in new study. This clinical trial is the first U.S.
DALLAS, March 15, 2011 /PRNewswire/ -- Children's Medical Center Dallas (Children's) http://childrens.com is launching a critical stroke initiative to diagnose and treat strokes in children.
RESEARCH TRIANGLE PARK, N.C., March 3, 2011 /PRNewswire/ -- Talecris Biotherapeutics, Inc. (TLCR) announced today that it has been granted orphan drug designation by the European Commission for the development of Plasmin (human) to treat acute peripheral arterial occlusion (aPAO).
Whether or not you're a fan of Indian, Southeast Asian or Middle Eastern food, stroke researchers at Cedars-Sinai Medical Center say you might become fond of one of their key spices.
DALLAS, Feb. 16, 2011 /PRNewswire/ -- Children's Medical Center Dallas (Children's) http://childrens.com is launching a critical stroke initiative to diagnose and treat strokes in children.
Every minute counts after the onset of a stroke.
Less than one-third of acute stroke patients treated with intravenous tissue plasminogen activator (tPA) receive the clot-busting drug within 60 minutes of their hospital arrival.
Among patients who have had strokes but aren't sure when symptoms began, magnetic resonance imaging (MRI) can help distinguish who might benefit from clot-busting drugs while facing acceptable risk.